Genetics, gene expression and bioinformatics of the pituitary gland

Hormone Research

Volumn 71, Issue SUPPL. 2, 2009, Pages 101-115

  Davis, Shannon W ^a   Potok, Mary Anne ^a   Brinkmeier, Michelle L ^a   Carninci, Piero ^b   Lyons, Robert H ^a   MacDonald, James W ^a   Fleming, Michelle T ^d   Mortensen, Amanda H ^a   Egashira, Noboru ^c   Ghosh, Debashis ^a   Steel, Karen P ^d   Osamura, Robert Y ^c   Hayashizaki, Yoshihide ^b   Camper, Sally A ^a,e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cell proliferation; Emx2; Prop1; Transcription factors

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; HOMEODOMAIN PROTEIN; HYPOPHYSIS HORMONE; LYMPHOID ENHANCER FACTOR 1; NOTCH RECEPTOR; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR EMX2; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PROP1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOINFORMATICS; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC RISK; GENETICS; HORMONE DEFICIENCY; HYPERPLASIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, MUTANT STRAINS; NEOPLASM PROTEINS; PITUITARY GLAND; PITUITARY HORMONES; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 66749108673     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000192447     Document Type: Conference Paper

References (94)

1. Kelberman D, Dattani MT: Hypothalamic and pituitary development: novel insights into the aetiology. Eur J Endocrinol 2007; 157(suppl 1):S3-S14.
2. Cushman LJ, Showalter AD, Rhodes SJ: Genetic defects in the development and function of the anterior pituitary gland. Ann Med 2002; 34: 179-191.
3. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji M, Norris D, Rastan S, Stevanovic M, Goodfellow PN, Lovell-Badge R: A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 1996; 122: 509-520.
4. Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R, Carmignac D, Lovell-Badge R, Robinson IC, Dattani MT: Mutations within Sox2/sox2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest 2006; 116: 2442-2455.
5. Meijlink F, Beverdam A, Brouwer A, Oosterveen TC, Berge DT: Vertebrate aristaless-related genes. Int J Dev Biol 1999; 43: 651-663.
6. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, Lovell-Badge R: Sox3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 2004; 36: 247-255.
7. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carrière C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG: Pituitary lineage determination by the prophet of pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327-333.
8. Suh H, Gage PJ, Drouin J, Camper SA: Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 2002; 129: 329-337.
9. Galliot B, de Vargas C, Miller D: Evolution of homeobox genes: Q50 paired-like genes founded the paired class. Dev Genes Evol 1999; 209: 186-197.
10. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA: The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of rpx transcription and initiation of lineage specific cell proliferation. Mol Endocrinol 1996; 10: 1570-1581.
11. Hermesz E, Mackem S, Mahon KA: Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate, and Rathke's pouch of the mouse embryo. Development 1996; 122: 41-52.
12. Thomas PQ, Johnson BV, Rathjen J, Rathjen PD: Sequence, genomic organization, and expression of the novel homeobox gene Hesx1. J Biol Chem 1995; 270: 3869-3875.
13. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990; 347: 528-533.
14. Nasonkin IO, Ward RD, Raetzman LT, Seasholtz AF, Saunders TL, Gillespie PJ, Camper SA: Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 2004; 13: 2727-2735.
15. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS: Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. Endocrinology 1993; 132: 2518-2524.
16. O'Hara BF, Bendotti C, Reeves RH, Oster-Granite ML, Coyle JT, Gearhart JD: Genetic mapping and analysis of somatostatin expression in Snell dwarf mice. Mol Brain Res 1988; 4: 283-292.
17. Buckwalter MS, Katz RW, Camper SA: Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 1991; 10: 515-526.
18. Cogan J, Wu W, Phillips JI, Arnhold I, Agapito A, Fofanova O, Osorio M, Bircan I, Moreno A, Mendonca B: The Prop1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346-3349.
19. Cohen LE, Radovick S: Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002; 23: 431-442.
20. Deladoey J, Fluck C, Buyukgebiz A, Kuhlmann BV, Eble A, Hindmarsh PC, Wu W, Mullis PE: 'Hot spot' In the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999; 84: 1645-1650.
21. Karolyi IJ, Dootz GA, Halsey K, Beyer L, Probst FJ, Johnson KR, Parlow AF, Raphael Y, Dolan DF, Camper SA: Dietary thyroid hormone replacement ameliorates hearing deficits in hypothyroid mice. Mamm Genome 2007; 18: 596-608.
22. Ward RD, Stone BM, Raetzman LT, Camper SA: Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 2006; 20: 1378-1390.
23. Wang Y, Nathans J: Tissue/planar cell polarity in vertebrates: new insights and new questions. Development 2007; 134: 647-658.
24. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA: Role of PROP1 in pituitary gland growth. Mol Endocrinol 2005; 19: 698-710.
25. Douglas KR, Camper SA: Partial transcriptome of the developing pituitary gland. Genomics 2000; 70: 335-346.
26. Douglas KR, Kennell JA, Eswara P, Harrison TA, Patrianakos AI, Sprecher BS, Potok MA, Lyons RH, MacDougald OA, Camper SA: Identification of members of the Wnt signaling pathway in the embryonic pituitary gland. Mamm Genome 2001; 12: 843-851.
27. Brinkmeier ML, Potok MA, Cha KB, Gridley T, Stifani S, Meeldijk J, Clevers H, Camper SA: TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 2003; 17: 2152-2161.
28. Brinkmeier ML, Potok MA, Davis SW, Camper SA: TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 2007; 311: 396-407.
29. Cha KB, Douglas KR, Potok MA, Liang H, Jones SN, Camper SA: WNT5a signaling affects pituitary gland shape. Mech Dev 2004; 121: 183-194.
30. Potok MA, Cha KB, Hunt A, Brinkmeier ML, Leitges M, Kispert A, Camper SA: WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. Dev Dyn 2008; 237: 1006-1020.
31. Brantjes H, Roose J, van De Wetering M, Clevers H: All Tcf HMG box transcription factors interact with Groucho-related corepressors. Nucleic Acids Res 2001; 29: 1410-1419.
32. Zhu C, Dyer M, Uchikawa M, Kondoh H, Lagutin O: Six3-mediated auto repression and eye development requires its interaction with members of the Groucho-related family of co-repressors. Development 2002; 129: 2835-2849.
33. Carninci P, Waki K, Shiraki T, Konno H, Shibata K, Itoh M, Aizawa K, Arakawa T, Ishii Y, Sasaki D, Bono H, Kondo S, Sugahara Y, Saito R, Osato N, Fukuda S, Sato K, Watahiki A, Hirozane-Kishikawa T, Nakamura M, Shibata Y, Yasunishi A, Kikuchi N, Yoshiki A, Kusakabe M, Gustincich S, Beisel K, Pavan W, Aidinis V, Nakagawara A, Held WA, Iwata H, Kono T, Nakauchi H, Lyons P, Wells C, Hume DA, Fagiolini M, Hensch TK, Brinkmeier M, Camper S, Hirota J, Mombaerts P, Muramatsu M, Okazaki Y, Kawai J, Hayashizaki Y: Targeting a complex transcriptome: the construction of the mouse full-length CDNA encyclopedia. Genome Res 2003; 13: 1273-1289.
34. Brinkmeier ML, Davis SW, Carninci P, Mac-Donald J, Kawai J, Ghosh D, Hayashizaki Y, Robert H, Lyons RH: Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches. Genomics DOI 10.1016/j.ygeno.2008.11.010.
35. Pellegrini M, Mansouri A, Simeone A, Boncinelli E, Gruss P: Dentate gyrus formation requires emx2. Development 1996; 122: 3893-3898.
36. Lopez-Bendito G, Chan CH, Mallamaci A, Parnavelas J, Molnar Z: Role of emx2 in the development of the reciprocal connectivity between cortex and thalamus. J Comp Neurol 2002; 451: 153-169.
37. Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, O'Shea KS, Wood WM, Lloyd RV, Ridgway EC, Camper SA: Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol 1994; 8: 1420-1433.
38. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T: A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol 1991; 11: 6041-6049.
39. Qi Y, Ranish JA, Zhu X, Krones A, Zhang J, Aebersold R, Rose DW, Rosenfeld MG, Carriere C: ATBF1 is required for the Pit1 gene early activation. Proc Natl Acad Sci USA 2008; 105: 2481-2486.
40. Miquelajauregui A, Van de Putte T, Polyakov A, Nityanandam A, Boppana S, Seuntjens E, Karabinos A, Higashi Y, Huylebroeck D, Tarabykin V: Smad-interacting protein-1 (Zfhx1b) acts upstream of Wnt signaling in the mouse hippocampus and controls its formation. Proc Natl Acad Sci USA 2007; 104: 12919-12924.
41. Verstappen G, van Grunsven LA, Michiels C, Van de Putte T, Souopgui J, Van Damme J, Bellefroid E, Vandekerckhove J, Huylebroeck D: Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1b/SIP1 and NuRD corepressor complex. Hum Mol Genet 2008; 17: 1175-1183.
42. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM: Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005; 65: 10214-10222.
43. Mowat DR, Croaker GD, Cass DT, Kerr BA, Chaitow J, Ades LC, Chia NL, Wilson MJ: Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet 1998; 35: 617-623.
44. Van de Putte T, Francis A, Nelles L, van Grunsven LA, Huylebroeck D: Neural crestspecific removal of ZFHX1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome. Hum Mol Genet 2007; 16: 1423-1436.
45. Raetzman LT, Ward R, Camper SA: Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 2002; 129: 4229-4239.
46. Sheng HZ, Zhadanov AB, Mosinger BJ, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang SP, Mahon KA, Westphal H: Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996; 272: 1004-1007.
47. Takuma N, Sheng HZ, Furuta Y, Ward JM, Sharma K, Hogan BLM, Pfaff SL, Westphal H, Kimura S, Mahon KA: Formation of Rathke's pouch requires dual induction from the diencephalon. Development 1998; 125: 4835-4840.
48. Roberson MS, Schoderbek WE, Tremml G, Maurer RA: Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor. Mol Cell Biol 1994; 14: 2985-2993.
49. Porter FD, Drago J, Xu Y, Cheema SS, Wassif C, Huang SP, Lee E, Grinberg A, Massalas JS, Bodine D, Alt F, Westphal H: Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development 1997; 124: 2935-2944.
50. Mangale VS, Hirokawa KE, Satyaki PR, Gokulchandran N, Chikbire S, Subramanian L, Shetty AS, Martynoga B, Paul J, Mai MV, Li Y, Flanagan LA, Tole S, Monuki ES: Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate. Science 2008; 319: 304-309.
51. Rhee H, Polak L, Fuchs E: Lhx2 maintains stem cell character in hair follicles. Science 2006; 312: 1946-1949.
52. Richter K, Pinto do OP, Hagglund AC, Wahlin A, Carlsson L: Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression. Haematologica 2003; 88: 1336-1347.
53. Mandel S, Rechavi G, Gozes I: Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Dev Biol 2007; 303: 814-824.
54. Borozdin W, Graham JM Jr, Bohm D, Bamshad MJ, Spranger S, Burke L, Leipoldt M, Kohlhase J: Multigene deletions on chromosome 20q13.13-q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay. Hum Mutat 2007; 28: 830.
55. Mandel S, Gozes I: Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. J Biol Chem 2007; 282: 34448-34456.
56. Poulin G, Turgeon B, Drouin J: NeuroD1/b2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 1997; 17: 6673-6682.
57. Mandel S, Spivak-Pohis I, Gozes I: ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. J Mol Neurosci 2008; 35: 127-141.
58. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S: Defects of urogenital development in mice lacking Emx2. Development 1997; 124: 1653-1664.
59. Noonan FC, Mutch DG, Ann Mallon M, Goodfellow PJ: Characterization of the homeodomain gene Emx2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers. Genomics 2001; 76: 37-44.
60. Gangemi RM, Daga A, Muzio L, Marubbi D, Cocozza S, Perera M, Verardo S, Bordo D, Griffero F, Capra MC, Mallamaci A, Corte G: Effects of emx2 inactivation on the gene expression profile of neural precursors. Eur J Neurosci 2006; 23: 325-334.
61. Davis S, Camper S: Noggin regulates Bmp4 activity during pituitary induction. Dev Biol 2007; 305: 145-160.
62. Ericson J, Norlin S, Jessell TM, Edlund T: Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 1998; 125: 1005-1015.
63. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG: Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998; 12: 1691-1704.
64. Treier M, O'Connell S, Gleiberman A, Price J, Szeto DP, Burgess R, Chuang P-T, McMahon AP, Rosenfeld MG: Hedgehog signaling is required for pituitary gland development. Development 2001; 128: 377-386.
65. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld MG: Homeodomain-mediated betacatenin-dependent switching events dictate cell-lineage determination. Cell 2006; 125: 593-605.
66. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C: An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000; 127: 483-492.
67. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, Itoh N: Fgf10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000; 277: 643-649.
68. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E: Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 2003; 100: 1034-1039.
69. Giacomini D, Paez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E: Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 2006; 147: 247-256.
70. Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ: Developmental regulation of notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 2004; 265: 329-340.
71. Raetzman LT, Cai JX, Camper SA: Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 2007; 304: 455-466.
72. Raetzman LT, Wheeler BS, Ross SA, Thomas PQ, Camper SA: Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 2006; 20: 2898-2908.
73. Asa SL, Ezzat S: Genetics and proteomics of pituitary tumors. Endocrine 2005; 28: 43-47.
74. Farrell WE: Pituitary tumours: findings from whole genome analyses. Endocr Relat Cancer 2006; 13: 707-716.
75. Heaney AP, Melmed S: Molecular targets in pituitary tumours. Nat Rev Cancer 2004; 4: 285-295.
76. Chandrasekharappa SC, Guru SC, Manickam P, Olufeni S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-406.
77. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006; 312: 1228-1230.
78. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S: Early involvement of estrogeninduced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999; 5: 1317-1321.
79. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Bronstein M, Melmed S: Pituitary tumor transforming gene expression in human pituitary adenomas. J Clin Endocrinol Metab 1999; 84: 761-767.
80. Zou H, McGarry TJ, Bernal T, Kirschner MW: Identification of a vertebrate sisterchromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999; 285: 418-422.
81. Yu R, Ren SG, Horwitz GA, Wang Z, Melmed S: Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Mol Endocrinol 2000; 14: 1137-1146.
82. Qian X, Scheithauer BW, Kovacs K, Lloyd RV: DNA microarrays: recent developments and applications to the study of pituitary tissues. Endocrine 2005; 28: 49-56.
83. Abbud RA, Kelleher R, Melmed S: Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression. Endocrinology 2004; 145: 867-880.
84. Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV: Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocrine 2006; 29: 435-444.
85. Mould AW, Duncan R, Serewko-Auret M, Loffler KA, Biondi C, Gartside M, Kay GF, Hayward NK: Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for Menin in transcription, cell cycle and chromatin remodelling. Int J Cancer 2007; 121: 776-783.
86. Cushman LJ, Watkins-Chow DE, Brinkmeier ML, Raetzman LT, Radak AL, Lloyd RV, Camper SA: Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility. Hum Mol Genet 2001; 10: 1141-1153.
87. Ward RD, Davis SW, Cho M, Esposito C, Lyons RH, Cheng JF, Rubin EM, Rhodes SJ, Raetzman LT, Smith TP, Camper SA: Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene. Mamm Genome 2007; 18: 521-537.
88. Vesper AH, Raetzman LT, Camper SA: Role of prophet of pit1 (PROP1) in gonadotrope differentiation and puberty. Endocrinology 2006; 147: 1654-1663.
89. Egashira N, Minematsu T, Miyai S, Takekoshi S, Camper S, Osamura R: Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes. Acta Histochem Cytochem 2008; 41: 47-57.
90. Brinkmeier ML, Stahl JH, Gordon D, Ross BD, Sarapura VD, Dowding JM, Kendall SK, Lloyd RV, Ridgway EC, Camper SA: Thyroid hormone responsive pituitary hyperplasia independent of somatostatin receptor 2. Mol Endocrinol 2001; 15: 2129-2136.
91. Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA: Targeted disruption of the pituitary glycoprotein hormone alphasubunit produces hypogonadal and hypothyroid mice. Genes Dev 1995; 9: 2007-2019.
92. Stahl JH, Kendall SK, Brinkmeier ML, Greco TL, Watkins-Chow DE, Canpos-Barros A, Lloyd RV, Camper SA: Thyroid hormone is essential for pituitary somatotropes and lactotropes. Endocrinology 1999; 140: 1884-1892.
93. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM: Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437: 376-380.
94. Hillier LW, Marth GT, Quinlan AR, Dooling D, Fewell G, Barnett D, Fox P, Glasscock JI, Hickenbotham M, Huang W, Magrini VJ, Richt RJ, Sander SN, Stewart DA, Stromberg M, Tsung EF, Wylie T, Schedl T, Wilson RK, Mardis ER: Whole-genome sequencing and variant discovery in C. elegans. Nat Methods 2008; 5: 183-188.